Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

All Content

  • 1
    News

    EMPEROR-Preserved: Empagliflozin scores HFpEF breakthrough

    August 27, 2021

    Empagliflozin is the first treatment to produce an unequivocal, hard-endpoint benefit in patients with heart failure with preserved ejection fraction, a practice-changing result.

  • 1
    News

    Genetic link may tie cannabis use disorder to severe COVID-19

    August 27, 2021

    “These data have important implications for policy regarding vaccination as well as treatment prioritization,” said lead author Dr. Alexander S. Hatoum.

  • 1
    News

    COVID-19: New GI symptoms don’t raise death risk in IBD

    August 27, 2021

    International registry data show new onset of GI symptoms is common in IBD patients with COVID-19 regardless of IBD disease status.

  • News

    Time to positivity doesn’t predict mortality in bloodstream infections with enterococci

    August 26, 2021

    The researchers found no significant association between risk for death and time to positivity with bloodstream infections with E faecalis, VSEfm, or VREfm, or its cutoffs.

  • 1
    News

    ACE-I or ARB therapy in patients with low eGFR

    August 26, 2021

    Is it safe to continue angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) therapy in patients whose estimated glomerular filtration rate (eGFR) has decreased to below 30 mL/min per 1.73 m2?

  • News

    One-third in U.S. had been infected by SARS-CoV-2 through 2020: Study

    August 26, 2021

    “We have not turned the corner on COVID-19 and are nowhere near herd immunity – if it exists for SARS-CoV-2.”

  • 1
    News

    Efficacy of gabapentin for treatment of alcohol use disorders

    August 25, 2021

    Can gabapentin be used in the treatment of alcohol use disorder (AUD) to reduce heavy drinking and maintain abstinence?

  • News

    New tool predicts pain relief after gallbladder surgery

    August 25, 2021

    “Until now, we did not know which patient with which symptoms would benefit most from this operation.”

  • 1
    News

    Children and COVID: New cases soar to near-record level

    August 24, 2021

    Vaccine initiations were down for the second consecutive week, but COVID-related deaths showed a big increase.

  • News

    U.S. kidney transplants grow in number and success

    August 24, 2021

    Data from 1996 to 2019 show more U.S. kidney transplants recently than ever before, and steady improvements in graft and patient survival.

Previous1 … 24 25 26 27 28 … 861Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences